0 AMP-activated protein kinase (AMPK) is recognized as an important intracellular energy sensor, shutting down energyconsuming processes and turning on energy-generating processes. Discovery of target proteins of AMPK has dramatically increased in the past 10 years. Historically, AMPK was first shown to regulate fatty acid and cholesterol synthesis, but is now hypothesized to take part in the regulation of energy/fuel balance not only at the cellular level but also at the level of the whole organism. In this brief review we will discuss some of the roles of AMPK in skeletal muscle. International Journal of Obesity (2008) 32, S13-S17. doi:10. 1038/ijo.2008.117 Keywords: AMPK; contraction; exercise; energy balance; insulin sensitivity
Introduction
According to the World Health Organization, type 2 diabetes mellitus has become one of the most prevailing diseases worldwide with approximately 160 million people suffering from this condition. A major hallmark of type 2 diabetes mellitus is skeletal muscle insulin resistance, and as this tissue is responsible for clearing most of the available glucose, increasing insulin sensitivity within this tissue is thought to be a beneficial treatment strategy. Interestingly, like physical activity, some of the antidiabetic drugs used are known to activate 5 0 AMP-activated protein kinase (AMPK), which may promote beneficial effects, including glucose uptake into skeletal muscle. [1] [2] [3] Furthermore, pharmacological AMPK activation promotes insulin sensitivity, and current working hypotheses include significant roles of AMPK for the insulin-sensitizing effects of not only exercise but also of antidiabetic drugs targeting skeletal muscle. Understanding the AMPK system in skeletal muscle and how this is regulated is therefore thought to be important for development of antidiabetic treatment regimes. This review will focus on some of the downstream consequences of AMPK activation in resting and exercised/contracted skeletal muscle.
Expression of AMPK in skeletal muscle
AMPK is a heterotrimeric serine/threonine protein kinase consisting of three subunits of which one (a) is catalytic and two (b, g) have regulatory functions. Multiple mammalian isoforms of the three subunits exist and all subunits are differentially expressed in rodent and human skeletal muscle depending on muscle fibre type composition (for references see Wojtaszewski et al.
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) Two a-subunits (a1, a2), two b-subunits (b1, b2) and three g-subunits (g1, g2, g3) have been characterized and are all encoded from different genes. 5 Although all subunits of AMPK seem to be expressed in human skeletal muscle tissue, only three AMPK heterotrimers (a1b2g1, a2b2g1 and a2b2g3) seem to exist in vastus lateralis muscle, 4 and these three heterotrimers account for the AMPK activity present in this tissue. 6 Importantly, muscle tissues are heterogeneous containing various nonmuscular cell types as well as different muscle fibre types. Future studies will have to clarify whether all the above heterotrimers are to be found within the muscle fibre per se and whether, as in rodents, fibre type-specific isoform expression exists. The AMPK heterotrimer composition is not as fully described in rodent skeletal muscle; however, evidence suggests that the b1 and the g3 regulatory subunits are to be found predominantly in slow and fast twitch glycolytic muscles, respectively. [7] [8] [9] As in humans, the g3 isoform in rodent muscle is also predominantly associated with the a2 catalytic subunit. 8, 9 The existence of a small but significant amount of the b1 subunit in muscle of rats makes it likely that the heterotrimer composition is different from that seen in human muscle (JB Birk and JFP Wojtaszewski, unpublished observation).
Regulation of AMPK activity
AMPK activation is induced in response to diverse stimuli that disturb the energy balance of the cell either by inhibiting ATP generation (for example, heat shock, hypoxia or ischemia) or accelerating ATP expenditure (for example, contraction of skeletal muscle) resulting in an increase in the AMP/ATP ratio. 5 This increase in AMP levels leads to allosteric activation of AMPK through AMP binding to the g-subunit. 10 Recent data suggest that AMP binding also induces a conformational change in the kinase domain leading to protection of Thr172 from dephosphorylation. Thus, increases in AMP levels play dual roles in activation of AMPK. 11, 12 The tumour suppressor LKB1 and the Ca 2 þ /CaMdependent protein kinase kinases are known AMPK kinases in skeletal muscle, 13 and they covalently modify Thr172
AMPK. 14 In situ electrical stimulation-induced AMPK phosphorylation/activity is abolished to a large extent in the absence of LKB1, and thus, at least under these conditions, LKB1 seems to be the principal AMPK regulator in mouse skeletal muscle. 15, 16 In skeletal muscle, AMPK is activated by acute exercise in both rodents and humans in an exercise intensity-dependent manner. Exercise at 60-75% of VO 2peak appears to be necessary for AMPK activation in humans (for references see Wojtaszewski et al.
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) and at these intensities complexes containing a2-AMPK are regulated to a greater extent than complexes containing a1-AMPK. Exercise at a more moderate intensity (B50% of VO 2peak ) does not elicit any detectable AMPK activity unless exercise is continued until exhaustion. 18 In muscle with a mixed content of fibre types, the activation of AMPK signalling will likely be affected by fibre type recruitment as this is a significant factor depending on both exercise duration and intensity. Although circulating adipokines such as leptin and adiponectin, as well as interleukin 6, have been shown to activate AMPK in skeletal muscle, [19] [20] [21] AMPK activation during exercise seems, at least in part, to be local in nature, as AMPK activation occurs in isolated rodent muscle in vitro 22 and because AMPK activation in human skeletal muscle during one-legged exercise occurs only in the exercising muscle. 23 Whether the initiating factor regulating AMPK in skeletal muscle during contraction/exercise is only a function of changes in adenosine nucleotides is questionable as roles of both calcium and reactive oxygen species have been suggested. 24 Regulation of specific AMPK heterotrimers and possible downstream targets
As mentioned above it was recently shown that only three AMPK heterotrimers seem to exist in human vastus lateralis muscle. 4 One of the questions raised based on this observation was under what conditions the individual trimers were activated during exercise and furthermore whether some of the biological effects known to be mediated by AMPK could be ascribed to activation of any of these trimer complexes. It was found that exercise at high intensity led to increased a2b2g3 AMPK activity only, and that the activities of the two remaining complexes were either unchanged or decreased. 6 In addition, activity of a2b2g3 AMPK was found to correlate with ACCb Ser221 phosphorylation, suggesting that this complex may mediate regulation of ACCb activity. Exercise performed at a lower intensity for a longer period of time is also known to activate AMPK. However, when we dissected AMPK activity into the three heterotrimers in muscle samples from subjects performing a 90 min exercise trial at 67% of VO 2peak , we observed that activity of a2b2g1 AMPK was increased with a much slower time course than that of a2b2g3 AMPK. 25 Moreover, when we measured phosphorylation of Akt substrate of 160 kDa (AS160), we found it to correlate with the activation pattern of a2b2g1 but not to that of a2b2g3 AMPK. Together with the observations in mouse skeletal muscle that contraction-mediated AS160 phosphorylation is dependent on complexes of AMPK containing the a2-subunit but not the g3-subunit, 26, 27 it is likely that a2b2g1 AMPK may be mediating contraction and exercise effects on AS160.
Maintaining energy balance during exercise: involvement of AMPK During exercise, skeletal muscles consume energy in the form of ATP required for cross bridge cycling, ion pumping activity and for general maintenance of cellular homoeostasis. Moderate-intensity exercise performed at steady state, does not normally lead to alterations in ATP levels indicating that the rate of ATP consumption matches ATP production. 28 Levels of adenosine and inosine monophosphate (AMP/ IMP), reflecting the balance between rate of ATP utilization and production, are also kept at resting levels during steady state exercise unless exercise is continued until exhaustion. 28, 29 However, if mice having a whole-body knockout (KO) of the a2-AMPK subunit are performing treadmill running at the same absolute intensity as their wild-type littermates, disturbed muscle energy balance reflected by reduced ATP content and an increase in AMP/IMP levels is evident both when mice are performing short-term highintensity and long-term moderate-intensity exercise. 30, 31 In line with these findings, muscle-specific LKB1 deficient mice are unable to maintain muscular energy levels during in vitro contraction to the same extent as wild-type mice. 16 In some 
) of the models in which AMPK signalling has been modified, force production (o10 min) in isolated muscle seems to be well maintained, whereas in vivo exercise performance (typically 410 min) is impaired in all those models in which it has been investigated (a2KO, 30 LKB1KO, 15 a2KD, 36 a2Tgi). 37 Although it is far too early to draw any firm conclusion it could be speculated that oxidative metabolism is impaired in the muscle of these miceFeither as a result of impaired substrate delivery or mitochondria oxidative capacity. However, factors outside the muscle tissue can have significant influence on wholebody exercise performance. Interestingly, the quantity of glycogen per gram tissue in muscle compared with liver is B1:20 and B1:2 in mice and humans, respectively. This difference is largely based on very low relative glycogen content in mouse muscle. Thus, it has been speculated that liver glycogen rather than muscle glycogen is the preferred glucose source for mouse skeletal muscle during exercise. This view is supported by recent findings showing that manipulation of muscle glycogen content does not alter exercise performance in mice, 38, 39 and that liver glycogen content is also depleted during exhaustive exercise. 40 If a2-AMPK KO mice are exercised at moderate intensity for 1 h, liver glycogen breakdown is markedly elevated compared with wild-type animals (unpublished observations). Speculatively, the lack of AMPK may compromise fatty acid oxidation or mitochondrial respiration in general, and may induce a higher reliance on exogenous glucose for anaerobic or aerobic metabolism in the working muscle, and in this way accelerate the development of fatigue.
Involvement of AMPK in mitochondrial biogenesis in skeletal muscle
Early studies suggested that AMPK plays a role in mitochondrial biogenesis in skeletal muscle, as chronic activation of AMPK in rats and mice with AICAR or b-guanadinopropionic acid increases mitochondrial content and expression of mitochondrial proteins. [41] [42] [43] Indeed, in transgenic mice expressing a kinase dead a2-AMPK subunit in skeletal muscle, chronic b-guanadinopropionic acid-induced increase in mitochondrial biogenesis was totally abolished 44 and in whole-body a2-AMPK KO mice, chronic AICAR treatment did not result in any increased content of mitochondrial marker proteins in skeletal muscle. 45 Peroxisome proliferator-activated receptor g co-activator-1a (PGC1a) is a co-activator of certain transcription factors and is expressed in skeletal muscle. It is believed that PGC-1a is a key protein involved in induction of mitochondrial biogenesis 46 and that functional AMPK is required for PGC-1a gene expression. 44 However, when a2-AMPK KO mice are exercised at moderate intensity for 1.5 h on a treadmill, the transcriptional activity from the PGC-1a gene and PGC-1a mRNA during and into the recovery was not different between wild-type and KO animals despite an B60% reduction in AMPK signalling during rest and exercise. 30 Thus, transcriptional regulation during exercise from the PGC-1a gene can occur without a2-AMPK present and may rely on other factors of which Ca 2 þ may be one of them. 47 In line, activity wheel exercise training increases expression of mitochondria marker proteins independent of a2-AMPK protein. 45 Yet in support of a role for AMPK signalling in expression of mitochondrial proteins, we have found that basal expression of a number of mitochondrial proteins was significantly reduced in nontrained a2-AMPK KO mice 45 and recently similar observations were reported in the LKB1 KO mouse. 15 Thus, it is likely that the disturbed energy balance observed during acute exercise in the a2-AMPK KO (and likely also in the LKB1 KO mouse) partly results from decreased ability to generate ATP.
The insulin-sensitizing effect of an acute bout of exercise: a role for AMPK?
Following an acute bout of exercise, glucose transport decreases gradually but the sensitivity of muscle to insulin is markedly increased in both rodents and humans. This increase in insulin sensitivity can persist for several days and although the muscle glycogen levels may play a part in exercise-induced increase in insulin sensitivity, this increased insulin action has been shown to occur even after full glycogen repletion (for references see Wojtaszewski et al. 48 ). The mechanism(s) for this increased insulin sensitivity is at present not known, but apparently it is not linked to changes in activity of the proteins involved in either the proximal or the more distal part of the classical phosphatidylinositol 3-kinase insulin signalling cascade. 49 At least two studies link acute AMPK activation and muscular insulin sensitivity. A single AICAR administration 24 h before measuring insulin action revealed a marked improvement in insulin-induced muscular glycogen synthesis in both normal-fat-fed and high-fat-fed induced insulin resistant rats. 50 Furthermore, in isolated rat muscle, increased insulin sensitivity comparable to that seen after exercise in vivo and muscle contraction in vitro occurred 3-4 h after acute AICAR treatment. 51 It is possible that the increase in post-exercise/post-AMPK activation induced insulin sensitivity in skeletal muscle may come about through modulation of AMPK targets further downstream in the insulin signalling pathway. Interestingly, one such target may be the recently discovered Akt substrate of 160 kDa (AS160). AS160 links insulin signalling and GLUT4 trafficking (for references see Watson 52 ), and is known to be a GTPase activating protein containing a GTPase activating protein homology domain in the Cterminal part of the protein. Thus, AS160 is thought to regulate the GTPase activity of Rab proteins to inhibit GLUT4 vesicle movement to, and/or fusion with, the plasma membrane. 53, 54 Phosphorylation of AS160 on one or more of the eight described phosphorylation sites by Akt inhibits its GTPase activating protein activity, such that in response to insulin, the GTP form of Rab proteins is elevated leading to an increased number of GLUT4 molecules in the plasma membrane. A recent study provided evidence that AS160 is involved in both insulin-and contraction-stimulated glucose uptake in skeletal muscle. 55 It was found that in tibialis anterior muscles expressing a mutated form of AS160 in which four phosphorylation sites on AS160 are mutated, both insulin-and contraction-stimulated glucose uptake was impaired. We and others have shown, using different transgenic animal models, that a2-AMPK is necessary for full AS160 phosphorylation during contractions but not during insulin stimulation in vitro. 26, 27 Thus, from these data, it seems possible that AS160 is a common effector molecule for both insulin-and contraction-mediated effects on glucose uptake, and that AMPK is likely to play a key role in contraction-induced AS160 phosphorylation. Therefore, one hypothesis could be that during exercise AS160 is phosphorylated and that this phosphorylation is sustained in the hours after the initial exercise bout, so that when insulin is applied, the effect on glucose uptake is enhanced. However, to date no conclusive data are available to implicate AMPK in enhanced post-exercise insulin sensitivity.
